Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

Complete biosynthesis of noscapine and halogenated alkaloids in yeast

Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast

De novo production of the plant-derived alkaloid strictosidine in yeast

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae

Biosynthesis of medicinal tropane alkaloids in yeast

De Novo Biosynthesis of Vindoline and Catharanthine in Saccharomyces cerevisiae

De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast

A yeast platform for high-level synthesis of natural and unnatural tetrahydroisoquinoline alkaloids

Intein-mediated Temperature Control for Complete Biosynthesis of Sanguinarine and Its Halogenated Derivatives in Yeast

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

Harnessing Synthetic Biology to Engineer Production and Secretion of Theanine in Saccharomyces Cerevisiae

De novo biosynthesis of diverse plant-derived styrylpyrones in Saccharomyces cerevisiae

Optimizing Oleaginous Yeast Cell Factories for Flavonoids and Hydroxylated Flavonoids Biosynthesis

Complete biosynthesis of cannabinoids and their unnatural analogues in yeast

Back to the plant: overcoming roadblocks to the microbial production of pharmaceutically important plant natural products

A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids

Optimizing yeast for high-level production of kaempferol and quercetin

Multilevel engineering of the upstream module of aromatic amino acid biosynthesis in Saccharomyces cerevisiae for high production of polymer and drug precursors

Improved protein glycosylation enabled heterologous biosynthesis of monoterpenoid indole alkaloids and their unnatural derivatives in yeast

Complete biosynthesis of opioids in yeast

Biosynthesis of β-lactam nuclei in yeast